I
Ifan Ali Wafa
Researcher at Airlangga University
Publications - 11
Citations - 87
Ifan Ali Wafa is an academic researcher from Airlangga University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 3 publications receiving 2 citations.
Papers
More filters
Journal ArticleDOI
mRNA Covid-19 vaccines in pregnancy: A systematic review
Nando Reza Pratama,Ifan Ali Wafa,David Setyo Budi,Manesha Putra,Manggala Pasca Wardhana,Citrawati Dyah Kencono Wungu +5 more
TL;DR: The available data suggested that the mRNA-based vaccines (Pfizer–BioNTech and Moderna) can prevent future SARS-CoV-2 infection and can be a safe option for pregnant women and their fetuses.
Journal ArticleDOI
Remdesivir for pregnancy: A systematic review of antiviral therapy for COVID-19
David Setyo Budi,Nando Reza Pratama,Ifan Ali Wafa,Manesha Putra,Manggala Pasca Wardhana,Citrawati Dyah Kencono Wungu +5 more
TL;DR: In this article , the use of remdesivir for pregnant patients with coronavirus disease 2019 (COVID-19) showed conflicting results in prior studies, and the authors aimed to systematically review its efficacy and safety for this population from the existing literature.
Journal ArticleDOI
Effectiveness of COVID-19 Vaccines against SARS-CoV-2 Omicron Variant (B.1.1.529): A Systematic Review with Meta-Analysis and Meta-Regression
Nando Reza Pratama,Ifan Ali Wafa,David Setyo Budi,Henry Sutanto,Tri Pudy Asmarawati,Gema Barlian Effendi,Citrawati Dyah Kencono Wungu +6 more
TL;DR: Compared to full dose only, a booster dose addition provides better protection against B. 1.1.529 infection, and it is important to note that the VE estimates decline over time, suggesting the need for a regular Covid-19 booster injection after certain period of time to maintain VE.
Posted ContentDOI
Covid-19 Vaccination in Pregnancy: A Systematic Review
Nando Reza Pratama,Ifan Ali Wafa,David Setyo Budi,Manesha Putra,Manggala Pasca Wardhana,Citrawati Dyah Kencono Wungu +5 more
TL;DR: In this article, the mRNA based vaccines (Pfizer-BioNTech and Moderna) can prevent future SARS-CoV-2 infections (p=0.0004) and did not affect pregnancy, delivery, and neonatal outcomes.